| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cryoport, Inc. | Director | Common Stock | 112,845 | $1,513,319 | $13.41 | 17 May 2024 | Direct |
| Celularity Inc | Director | Class A Common Stock | 67,416 | $277,080 | $4.11 | 19 Dec 2024 | Direct |
| BIOVIE INC. | Director | Common Stock | 40,643 | $19,265 | $0.4740 | 20 Nov 2024 | Direct |
| Celularity Inc | Director | Stock Option (Right to Buy) | 202,857 | 19 Dec 2024 | Direct | ||
| Celularity Inc | Director | Stock Option Grant (Right to Buy) | 118,111 | 27 Aug 2024 | Direct | ||
| Context Therapeutics Inc. | Director | Stock Option (right to buy) | 50,000 | 13 Jun 2024 | Direct | ||
| Frontier Investment Corp | Director | Ordinary Shares, $0.0001 par value | 31,250 | 30 Jun 2021 | Indirect economic interest for the value of the identified amount of shares. | ||
| Cryoport, Inc. | Director | Option (Right to Buy Common Stock) | 23,830 | 17 May 2024 | Direct | ||
| BIOVIE INC. | Director | Stock Option (right to buy) | 23,155 | 20 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CELU | Celularity Inc | 19 Dec 2024 | 2 | $0 | 4 | Director | 06 Jan 2025, 16:54 |
| BIVI | BIOVIE INC. | 20 Nov 2024 | 2 | $0 | 4 | Director | 07 Jan 2025, 17:24 |
| CELU | Celularity Inc | 27 Aug 2024 | 1 | $0 | 4 | Director | 28 Aug 2024, 17:26 |
| CELU | Celularity Inc | 27 Aug 2024 | 0 | $0 | 3 | Director | 28 Aug 2024, 17:24 |
| CNTX | Context Therapeutics Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 07:41 |
| CYRX | Cryoport, Inc. | 17 May 2024 | 2 | $0 | 4 | Director | 21 May 2024, 19:00 |
| CYRX | Cryoport, Inc. | 15 May 2024 | 1 | -$108,693 | 4 | Director | 16 May 2024, 17:30 |
| SIDU | Sidus Space Inc. | 18 Jan 2024 | 0 | $0 | 3 | Director | 24 Jan 2024, 09:48 |
| BIVI | BIOVIE INC. | 09 Nov 2023 | 1 | $0 | 4 | Director | 06 Dec 2023, 16:15 |
| BIVI | BIOVIE INC. | 22 Aug 2023 | 1 | -$37,827 | 4 | Director | 24 Aug 2023, 21:33 |
| CNTX | Context Therapeutics Inc. | 31 May 2023 | 1 | $0 | 4 | Director | 31 May 2023, 16:52 |
| BIVI | BIOVIE INC. | 22 May 2023 | 2 | -$67,288 | 4 | Director | 15 Jun 2023, 17:15 |
| CYRX | Cryoport, Inc. | 12 May 2023 | 2 | $0 | 4 | Director | 16 May 2023, 19:26 |
| CYRX | Cryoport, Inc. | 11 May 2023 | 1 | -$154,906 | 4 | Director | 12 May 2023, 18:22 |
| BIVI | BIOVIE INC. | 27 Mar 2023 | 3 | -$93,581 | 4 | Director | 06 Apr 2023, 21:02 |
| CYRX | Cryoport, Inc. | 01 Dec 2022 | 1 | -$142,316 | 4 | Director | 05 Dec 2022, 05:07 |
| BIVI | BIOVIE INC. | 23 Nov 2022 | 1 | $0 | 4 | Director | 18 Jan 2023, 15:22 |
| CYRX | Cryoport, Inc. | 16 Aug 2022 | 1 | -$116,588 | 4 | Director | 16 Aug 2022, 18:29 |
| CNTX | Context Therapeutics Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:09 |
| CYRX | Cryoport, Inc. | 29 Apr 2022 | 4 | $0 | 4 | Director | 03 May 2022, 20:00 |
| BIVI | BIOVIE INC. | 05 Apr 2022 | 1 | $0 | 4 | Director | 20 Apr 2022, 16:47 |
| CNTX | Context Therapeutics Inc. | 19 Oct 2021 | 0 | $0 | 3 | Director | 19 Oct 2021, 17:59 |
| CYRX | Cryoport, Inc. | 13 Sep 2021 | 7 | -$1,201,247 | 4 | Director | 15 Sep 2021, 19:09 |
| /report/000110465921091243-berman-richard-j-2021-06-30 | Frontier Investment Corp | 30 Jun 2021 | 0 | $0 | 3 | Director | 12 Jul 2021, 17:13 |
| CYRX | Cryoport, Inc. | 30 Apr 2021 | 2 | $0 | 4 | Director | 07 May 2021, 18:42 |
| BIVI | BIOVIE INC. | 02 Jan 2020 | 3 | $0 | 4 | Director | 29 Sep 2021, 10:56 |
| BIVI | BIOVIE INC. | 24 Jun 2019 | 0 | $0 | 3 | Director | 28 Sep 2021, 21:20 |